Liquidia Corp. (LQDA)
58.12
+2.91
(+5.27%)
USD |
NASDAQ |
Nov 12, 16:00
57.73
-0.39
(-0.67%)
After-Hours: 06:39
Liquidia Market Cap : 5.215B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.215B |
| November 11, 2026 | 4.954B |
| November 10, 2026 | 4.612B |
| November 09, 2026 | 4.295B |
| November 06, 2026 | 3.984B |
| November 05, 2026 | 3.992B |
| November 04, 2026 | 4.222B |
| November 03, 2026 | 3.760B |
| November 02, 2026 | 3.729B |
| October 30, 2026 | 4.015B |
| October 29, 2026 | 4.009B |
| October 28, 2026 | 4.074B |
| October 27, 2026 | 4.049B |
| October 26, 2026 | 3.897B |
| October 23, 2026 | 3.800B |
| October 22, 2026 | 3.536B |
| October 21, 2026 | 3.462B |
| October 20, 2026 | 3.239B |
| October 19, 2026 | 3.041B |
| October 16, 2026 | 3.061B |
| October 15, 2026 | 3.099B |
| October 14, 2026 | 3.024B |
| October 13, 2026 | 2.389B |
| October 12, 2026 | 2.465B |
| October 09, 2026 | 2.440B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.497B |
| October 07, 2026 | 2.377B |
| October 06, 2026 | 2.309B |
| October 05, 2026 | 2.463B |
| October 02, 2026 | 2.552B |
| October 01, 2026 | 2.494B |
| September 30, 2026 | 2.696B |
| September 29, 2026 | 6.298B |
| September 28, 2026 | 6.564B |
| September 25, 2026 | 6.097B |
| September 24, 2026 | 6.322B |
| September 23, 2026 | 6.013B |
| September 22, 2026 | 6.116B |
| September 21, 2026 | 5.919B |
| September 18, 2026 | 5.959B |
| September 17, 2026 | 6.094B |
| September 16, 2026 | 6.099B |
| September 15, 2026 | 5.856B |
| September 14, 2026 | 5.819B |
| September 11, 2026 | 5.947B |
| September 10, 2026 | 6.045B |
| September 09, 2026 | 6.159B |
| September 08, 2026 | 6.030B |
| September 04, 2026 | 6.118B |
| September 03, 2026 | 6.115B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 25.15B |
| Johnson & Johnson | 682.47B |
| Eli Lilly & Co. | 1.343T |
| Pfizer Inc. | 164.33B |
| Amneal Pharmaceuticals, Inc. | 7.560B |
Market Cap Related Metrics
| PS Ratio | 9.161 |
| Price to Free Cash Flow | 19.57 |
| Price | 58.12 |
| Earnings Yield | -2.12% |
| Operating PE Ratio | 19.44 |
| Normalized PE Ratio | 32.06 |